HomeNMRD • OTCMKTS
Nemaura Medical Inc
$0.089
Mar 28, 2:18:33 PM GMT-4 · USD · OTCMKTS · Disclaimer
StockUS listed security
Previous close
$0.080
Day range
$0.080 - $0.089
Year range
$0.068 - $1.25
Market cap
2.58M USD
Avg Volume
48.86K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
Operating expense
1.54M-5.09%
Net income
-2.16M-25.94%
Net profit margin
Earnings per share
-0.12-71.43%
EBITDA
-1.46M4.39%
Effective tax rate
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
137.42K-98.13%
Total assets
5.17M-60.12%
Total liabilities
23.00M0.77%
Total equity
-17.83M
Shares outstanding
28.90M
Price to book
-0.13
Return on assets
-54.70%
Return on capital
-112.37%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
-2.16M-25.94%
Cash from operations
-1.48M3.99%
Cash from investing
-10.43K81.91%
Cash from financing
-3.00M-76.51%
Net change in cash
-4.24M-53.16%
Free cash flow
1.19M170.82%
About
Nemaura Medical Inc. is a UK based Medical Technology company developing a wireless non-invasive blood glucose monitoring system called SugarBeAT. Wikipedia
Founded
2013
Employees
36
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu